SCIEQ1
Cancer & Metabolism
BMC
Cancer & Metabolism is an academic journal published by BMC. Identifiers: eISSN 2049-3002. Indexed in SCIE. Metrics: JIF 5.3. Subject areas: CELL BIOLOGY, ONCOLOGY. tlooto lists 676 papers from this journal.
CiteScore
-
Scopus citation metric
SJR
-
SCImago rank
SNIP
-
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2049-3002
- Abbreviation
- CANCER METAB
- Publisher
- BMC
- Country
- -
Web of Science categories
SCIECELL BIOLOGY, ONCOLOGY
Scopus ASJC categories
No ASJC category data available.
Keywords
Oncology | Cell Biology
Papers in this journal
Recent papers
- Targeting FANCD2 to overcome enzalutamide resistance in prostate cancer
2026
- Oncometabolite fumarate impairs ATR-CHK1 signaling by succinating RPA1 in fumarate hydratase-deficient renal cell carcinoma cells
2026
- POU2F1 drives cholesterol biosynthesis and lipid remodeling through the DHCR24/ELOVL2 axis in endometrial cancer
2026
- Normoxic HIFα-mediated metabolic rewiring in cancer as a novel therapeutic target of tumor heterogeneity
2026
- Caloric restriction enhances radiosensitivity of colorectal tumors through the cGAS-STING pathway activation
2026
Most cited papers
- Mitochondrial reactive oxygen species and cancer
2014 · 728 citations
- Metformin directly acts on mitochondria to alter cellular bioenergetics
2014 · 402 citations
- Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration
2017 · 368 citations
- Mitochondria as biosynthetic factories for cancer proliferation
2015 · 358 citations
- Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways
2014 · 288 citations